When a treatment carries risk, the instinct is to compare it against doing nothing. In chronic pain, that comparison is usually made wrongly, because “doing nothing” is quietly treated as the zero-risk option.
It is not. Persistent, unmanaged pain has measurable effects on the brain, and those effects accumulate.
Pain keeps the stress axis switched on
Acute pain triggers the hypothalamic–pituitary–adrenal axis. That is appropriate and self-limiting: the threat resolves, the axis stands down.
Chronic pain does not resolve, so the axis does not stand down. The result is sustained cortisol exposure, and the structures most sensitive to it are the hippocampus, which consolidates memory, and the prefrontal cortex, which handles planning, attention and inhibition. Imaging studies in chronic pain populations have repeatedly reported reduced grey matter volume in these regions relative to controls.
That is not a metaphor for feeling worn down. It is a structural finding.
Pain inflames the brain, not just the tissue
Continuous nociceptive signalling activates microglia, the resident immune cells of the central nervous system. Activated microglia release pro-inflammatory signalling molecules, and sustained release of those molecules interferes with synaptic plasticity — the mechanism by which the brain forms and revises connections.
Clinically this presents as the symptom cluster patients describe long before anyone measures anything: brain fog, losing the thread mid-sentence, reading a paragraph three times, slowed processing. Patients are frequently told this is depression, or age, or the medication. Some of it is the pain.
There is also a simpler mechanism running alongside the biology. Pain occupies attention. Cognitive bandwidth spent on an unrelenting signal is bandwidth unavailable for memory formation and decision-making.
The comparison that actually matters
The evidence base here needs stating carefully, because it is frequently overstated in both directions.
Observational cohorts have reported associations between chronic pain and later dementia diagnoses, with effect sizes varying by cohort, pain definition and follow-up. These are associations. They do not establish that pain causes dementia, and confounding by shared risk factors — vascular disease, sleep disruption, inactivity, metabolic dysfunction — is difficult to exclude.
What the data supports is narrower and still useful: untreated chronic pain travels with cognitive decline often enough, and through plausible enough mechanisms, that treating it as harmless is not defensible.
The honest framing is that both columns have costs. Long-term high-dose opioid therapy carries real risks, and this practice spends most of its clinical effort reducing that burden rather than adding to it — see opioid bankruptcy and why tapering is a bridge, not a destination. The mistake is assuming the alternative column is empty. Choosing not to treat is a choice with consequences, and it should be made deliberately rather than by default.
What treating it looks like
The practical answer to “pain is damaging the brain” is not a prescription. It is to find and treat the pain generator, and to address the terrain the pain is running on.
- Identify the source. Facet-mediated, discogenic, neuropathic and centrally maintained pain are different problems with different treatments. Diagnostic blocks localize the first; see facet joint pain and the medial branch nerves.
- Treat it directly. Interventional options — radiofrequency ablation, epidural and sympathetic blocks, neuromodulation — target the generator rather than masking the signal.
- Fix the metabolic substrate. Insulin resistance and visceral adiposity are pro-inflammatory states that lower pain thresholds. This is not adjacent to pain treatment; it often is the treatment. See hyperinsulinemia and chronic pain and treating metabolic disease at the dietary root cause.
- Protect sleep. Sleep disruption amplifies pain and independently impairs cognition, and the two feed each other.
Where analgesia has a role while those measures take effect is a bounded clinical judgement, made per patient, and genuinely contested in the field. It is a bridge, not a destination.
Frequently asked questions
Does chronic pain cause dementia?
The evidence shows an association, not established causation. Observational cohorts report higher rates of later cognitive decline among people with chronic pain, but shared risk factors are hard to exclude. The reasonable conclusion is that untreated pain is a risk worth addressing, not that it guarantees dementia. See reducing pain risk with early brain stimulation for one line of work on early intervention.
Is brain fog from the pain or the medication?
It can be either, and frequently both. Opioids, gabapentinoids, antidepressants and sleep medications all affect cognition, and so does the pain itself. Untangling it requires reviewing the whole regimen rather than assuming. Do not start, stop, or change any medication without consulting your physician.
If opioids are risky, what is the alternative?
Treating the pain generator directly. That is what interventional pain medicine does — see radiofrequency ablation — combined with metabolic work that lowers the inflammatory baseline. See treating metabolic disease at the dietary root cause.
Can the brain changes reverse?
Some imaging studies have reported partial normalization of grey matter measures after pain is successfully treated, which is encouraging but not a guarantee. Individual results vary.
Where can I be evaluated?
Padda Institute, 4477 Woodson Rd, Suite 100, St. Louis, MO 63134, serving the St. Louis region across Missouri and Illinois. Call (314) 481-5000 or text (314) 886-5902.
Key takeaways
- Untreated chronic pain sustains cortisol exposure and microglial activation, both unfavourable to memory and executive function.
- Reported links between chronic pain and later cognitive decline are associations, not proven causation — but the mechanisms are plausible.
- The real comparison is between two columns of risk, not between a risky treatment and a safe nothing.
- Treatment here means identifying and treating the pain generator plus fixing the metabolic terrain.
- Brain fog in chronic pain deserves a regimen review, not an assumption.
Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed August 2026.
This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician.
Find out what is actually driving your pain
Evaluation at the Padda Institute starts by identifying the pain generator and the metabolic terrain it is running on — not by adding another prescription.
Book an appointment or call (314) 481-5000 · text (314) 886-5902
Padda Institute Center for Interventional Pain Management, 4477 Woodson Rd, Suite 100, St. Louis, MO 63134 — serving the St. Louis region across Missouri and Illinois.
Dr. Gurpreet Singh Padda, MD, MBA, MHP
